News
MapLight Therapeutics, a clinical-stage biopharmaceutical company focused on improving the lives of patients suffering from debilitating CNS disorders, announced the initiation of a phase 2 study to ...
Our Bureau, Bengaluru Thursday, July 10, 2025, 15:45 Hrs [IST] ...
Charlestown, Massachusetts Thursday, July 10, 2025, 15:30 Hrs [IST] ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback